Specifically, it activates three distinct receptor pathways simultaneously: GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose- dependent Insulinotropic Polypeptide), and Glucagon
What makes it different: Once daily, any time of day No empty stomach requirement No waiting period before eating or drinking No refrigeration needed In clinical trials, the highest dose produced an average weight loss of around 11 percent over 72 weeks in adults without diabetes
[5] For women taking tirzepatide with oral contraceptives, backup contraception may be advised during dose escalation due to potential reduced contraceptive exposure
And some people dont respond to GLP-1 medicines at all
Phase 1/2 data (N=125) showed that subcutaneous amycretin produced 13.1% body-weight loss at just 12 weeks, a rate that, if sustained, would project to over 25% at one year [9]